Aktis Oncology, Inc.
AKTS
$21.62
-$0.03-0.14%
NASDAQ
| 12/31/2024 | |||||
|---|---|---|---|---|---|
| Revenue | 933.00K | ||||
| Total Other Revenue | -- | ||||
| Total Revenue | 933.00K | ||||
| Cost of Revenue | 12.61M | ||||
| Gross Profit | -11.67M | ||||
| SG&A Expenses | 3.96M | ||||
| Depreciation & Amortization | -- | ||||
| Other Operating Expenses | -- | ||||
| Total Operating Expenses | 16.57M | ||||
| Operating Income | -15.64M | ||||
| Income Before Tax | -12.06M | ||||
| Income Tax Expenses | -- | ||||
| Earnings from Continuing Operations | -12.06M | ||||
| Earnings from Discontinued Operations | -- | ||||
| Extraordinary Item & Accounting Change | -- | ||||
| Minority Interest in Earnings | -- | ||||
| Net Income | -12.06M | ||||
| EBIT | -15.64M | ||||
| EBITDA | -15.19M | ||||
| EPS Basic | -16.06 | ||||
| Normalized Basic EPS | -10.04 | ||||
| EPS Diluted | -16.06 | ||||
| Normalized Diluted EPS | -10.04 | ||||
| Average Basic Shares Outstanding | 750.70K | ||||
| Average Diluted Shares Outstanding | 750.70K | ||||
| Dividend Per Share | -- | ||||
| Payout Ratio | -- | ||||